09/30/2024 7:35 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024 3:59 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024 4:20 PM | Ascendis Pharma A/S (Filer)
| Form 424B5 | |
09/18/2024 3:01 PM | Ascendis Pharma A/S (Filer)
| Form F-3ASR | |
09/16/2024 6:28 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 6:32 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024 3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
09/03/2024 4:10 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 4:11 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 4:14 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/12/2024 6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2024 5:07 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024 3:26 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024 3:08 PM | Ascendis Pharma A/S (Filer)
| Form SD Specialized Disclosure Report | |
05/14/2024 1:37 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024 8:16 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024 10:31 AM | Ascendis Pharma A/S (Subject) Bodenhoff Mads (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 8:39 PM | Ascendis Pharma A/S (Subject) Fairey William (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 8:47 AM | Ascendis Pharma A/S (Subject) Cha Albert (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 7:04 AM | Ascendis Pharma A/S (Subject) SPROGOE KENNETT (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 7:14 AM | Ascendis Pharma A/S (Subject) Morrison Lisa (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 6:52 AM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 6:37 AM | Ascendis Pharma A/S (Subject) JENSEN FLEMMING STEEN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 1:54 PM | Ascendis Pharma A/S (Subject) PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 2:07 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 2:17 PM | Ascendis Pharma A/S (Subject) RASMUSSEN PETER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 1:36 PM | Ascendis Pharma A/S (Subject) SMITH SCOTT THOMAS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 1:24 PM | Ascendis Pharma A/S (Subject) SINGEL STINA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 10:00 AM | Ascendis Pharma A/S (Subject) HOLTUG LARS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 4:13 PM | Ascendis Pharma A/S (Subject) Morrison Lisa (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 3:21 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024 5:17 PM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024 4:45 PM | Ascendis Pharma A/S (Subject) PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 2:17 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 4:14 PM | Ascendis Pharma A/S (Subject) Volck Birgitte (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 4:15 PM | Ascendis Pharma A/S (Subject) JENSEN FLEMMING STEEN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 4:16 PM | Ascendis Pharma A/S (Subject) SMITH SCOTT THOMAS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 10:40 AM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 8:17 AM | Ascendis Pharma A/S (Subject) Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
02/13/2024 10:57 AM | Ascendis Pharma A/S (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/12/2024 5:12 AM | Artisan Partners Limited Partnership (Filed by) Ascendis Pharma A/S (Subject)
| Form SC 13G/A | |
The Final Frontier (Ad) And a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it.
That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain. Here’s the full story for you. |
02/09/2024 1:17 PM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 7:35 AM | Ascendis Pharma A/S (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
02/07/2024 3:15 PM | Ascendis Pharma A/S (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
02/02/2024 12:18 PM | Ascendis Pharma A/S (Subject) WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
| Form SC 13G/A | |
01/29/2024 7:36 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 5:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 5:08 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/02/2024 5:08 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023 7:30 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2023 7:32 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/07/2023 1:53 PM | Ascendis Pharma A/S (Subject) Volck Birgitte (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2023 3:20 PM | Ascendis Pharma A/S (Subject) RASMUSSEN PETER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 5:04 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2023 7:30 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |